Acinar-ductal-carcinoma sequence in transforming growth factor-α transgenic mice

Annals of the New York Academy of Sciences

Volumn 880, Issue , 1999, Pages 219-230

  Schmid, Roland M ^a   Klöppel, Günther ^b   Adler, Guido ^a   Wagner, Martin ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; PROTEIN P53; TRANSFORMING GROWTH FACTOR ALPHA; ZYMOGEN GRANULE;

ACINAR CELL; ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; FIBROBLAST; GENE MUTATION; MOUSE; NONHUMAN; ONCOGENE K RAS; PANCREAS CARCINOMA; PANCREAS DUCT; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0032805074     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09526.x     Document Type: Conference Paper

References (39)

1. 1. SOMMERS, S.C., S.A. MURPHY, S. WARREN et al. 1954. Pancreatic duct hyperplasia and cancer. Gastroenterology 27: 629-640.
2. 2. CUBILLA, A.L. & P.J. FITZGERALD. 1975. Morphologial patterns of primary nonendocrine human pancreatic carcinoma. Cancer Res. 35: 2234-2248.
3. 3. KLÖPPEL, G., G. BOMMER, K. RÜCKERT et al. 1980. Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis. Virchows Arch. A 387: 221-223.
4. 4. KOZUKA, S., R. SASSA, T. TAKI et al. 1979. Relation of pancreatic duct hyperplasia to carcinoma. Cancer 43: 1418-1428.
5. 5. ALMOGUERA, C., D. SHIBATA, K. FORRESTER et al. 1988. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53: 549-554.
6. 6. SMIT, V.T.H.B.M., A.J.M. BOOT, A.M.M. SMITS et al. 1988. KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acid Res. 16: 7773-7782.
7. 7. GRÜNEWALD, K., J. LYONS & A. FRÖHLICH et al. 1989. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int. J. Cancer 43: 1037-1041.
8. 8. YANAGISAMA, A., K. OHTAKE, K. OHASHI et al. 1993. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic pancreatitis. Cancer Res. 53: 953-956.
9. 9. MOSKALUK, C.A., R.H. HRUBAN & S.E. KERN. 1997. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res. 57: 2140-2143.
10. 10. CALDAS, C., S.A. HAHN, L.T. DA COSTA et al. 1994. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet. 8: 27-32.
11. 11. NAUMANN, M., N. SAVITSKAIA, C. EILERT et al. 1996. Frequent codeletion of p16/ MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors. Gastroenterology 110: 1215-1224.
12. 12. BARTON, C.M., S.L. STADDON, C.M. HUGHES et al. 1991. Abnormalities of the p53 tumor suppressor gene in human pancreatic cancer. Br. J, Cancer 64: 1076-1082.
13. 13. RUGGERI, B., S.Y. ZHANG, J. CAAMANO et al. 1992. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumour suppressor genes. Oncogene 7: 1503-1511.
14. 14. SCARPA, A., P. CAPELLI, K. MUKAI et al. 1993. Pancreatic adenocarcinomas frequently show p53 gene mutations. Am. J. Pathol. 142: 1534-1543.
15. 15. PELLEGATA, N.S., F. SESSA, B. RENAULT et al. 1994, K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res. 54: 1556-1560.
16. 16. YOKOYAMA, M., Y. YAMANAKA, H. FRIESS et al. 1994. p53 expression in human pancreatic cancer correlates with enhanced biological aggressiveness. Anticancer Res. 14: 2477-2484.
17. 17. HAHN, S., A. SCHÜTTE, M. HOGQUE et al. 1996. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353.
18. 18. HÖHNE, M.W., M.-E. HALATSCH, G.F. KAHL et al. 1992. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res. 52: 2616-2619.
19. 19. HORII, A., S. NAKATSURU, Y. MIYOSHI et al. 1992. Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res. 52: 6696-6698.
20. 20. FRIESS, H., P. BERBERAT, M. SCHILLING et al. 1996. Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors. J. Mol. Med. 74: 35-42.
21. 21. BARTON, C.M., P.A. HALL & C.M. HUGHES. 1991. TGF-α and EGF in human pancreatic cancer. J. Pathol. 163: 111-116.
22. 22. LEMOINE, N.R., C.M. HUGES & C.M. BARTON. 1992. The epidermal growth factor receptor in human pancreatic cancer. J. Pathol. 166: 7-12.
23. 23. KORC, M., B. CHANDRASEKAR, Y. YAMANAKA et al. 1992. Overexpression of the epiermal growth factor receptor in human pancreatic cancer is associated with concomitant increase in the levels of epidermal growth factor and transforming growth factor alpha. J. Clin. Invest. 90: 1352-1360.
24. 24. YAMANAKA, Y., H. FRIESS, M.S. KOBRIN et al. 1993. Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressivenes. Anticancer Res. 13: 565-570.
25. 25. SMITH, J.J., R. DERYNCK & M. KORC. 1987. Production of transforming growth factor in human pancreatic cancer cells: evidence for a superagonist autocrine cycle. Proc. Natl. Acad. Sci. USA 84: 7567-7570.
26. 26. SANDGREN, E.P., N.C. LUETTEKE & R.D. PALMITER. 1990. Overexpression of TGF-α in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma on the breast. Cell 61: 1121-1135.
27. 27. JHAPPAN, C., C. STAHLE, R.N. HARKINS et al. 1990. TGF-α overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61: 1137-1146.
28. 28. WAGNER, M., H. LÜHRS, G. KLÖPPEL et al. 1998. Malignant transformation of duct-like cells originating from acini in mice overexpressing transforming growth factor a in the exocrine pancreas. Gastroenterology 115: 1254-1262.
29. 29. DE LISTLE, B.C. & C.D. LOGSDON. 1990. Pancreatic acinar cells in culture: expression of acinar and ductal antigens in a growth-related manner. Eur. J. Cell Biol. 51: 64-75.
30. 30. GITHENS, S., J.J. FINLEY & C.L. PATKE. 1987. Biochemical and histochemical characterization of cultured rat and hamster pancreatic ducts. Pancreas 2: 427-438.
31. 31. BOCKMAN, D.E. & G. MERLINO. 1992. Cytological changes in the pancreas of transgenic mice overexpressing transforming growth factor α. Gastroenterology 103: 1883-1892.
32. 32. PARSA, I., D.S. LONGNECKER & D.G. SCARPELLI. 1985. Ductal metaplasia of human exocrine pancreas and its association with carcinoma. Cancer Res. 45: 1285-1290.
33. 33. DUDEK, R.W., I.E.J. LAWRENCE & R.S. HILL. 1991. Induction of islet cytodifferentiation by fetal mesenchyme in adult pancreas ductal epithelium. Diabetes 40: 1041-1048.
34. 34. LEHV, M. & P.J. FITZGERALD. 1968. Pancreatic acinar cell regeneration. IV. Regeneration after surgical resection. Am. J. Pathol. 53: 513-535.
35. 35. BROCKENBROUGH, J.S., G.C. WEIR & S. BONNER-WEIR. 1988. Discordance of exocrine and endocrine growth after 90% pancreatectomy in rats. Diabetes 37: 232-236.
36. 36. POUR, P.M. 1988. Mechanism of pseudoductular (tubular) formation during pancreatic carcinogenesis in the hamster model. Am. J. Pathol. 130: 335-344.
37. 37. FLAKS, B. 1984. Histogencsis of pancreatic carcinogenesis in the hamster: ultrastructural evidence. Environ. Health Perspect. 56: 187-203.
38. 38. LONGNECKER, D.S., H. SHINOZUKA & A. DEKKER. 1980. Focal acinar cell dysplasia in human pancreas. Cancer 45: 534-540.
39. 39. CERY, W.L., K.A. MANGOLD & D.G. SCARPELLI. 1990. Activation of K-ras in transplantable pancreatic ductal adenocarcinomas of Syrian golden hamsters. Carcinogenesis 11: 2075-2079.